Business Description
Haleon PLC
ISIN : GB00BMX86B70
Compare
Compare
Traded in other countries / regions
HLN.UKHLN.USAH6D0.GermanyHLN1.Mexico IPO Date
2022-07-18Description
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.11 | |||||
| Equity-to-Asset | 0.49 | |||||
| Debt-to-Equity | 0.57 | |||||
| Debt-to-EBITDA | 4.55 | |||||
| Interest Coverage | 4.42 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 2.72 | |||||
| Beneish M-Score | -2.62 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.4 | |||||
| 3-Year EBITDA Growth Rate | 7.1 | |||||
| 3-Year EPS without NRI Growth Rate | 1.2 | |||||
| 3-Year FCF Growth Rate | 17.2 | |||||
| 3-Year Book Growth Rate | -14 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 10.17 | |||||
| Future 3-5Y Total Revenue Growth Rate | 3.35 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 62.27 | |||||
| 9-Day RSI | 59.02 | |||||
| 14-Day RSI | 55.94 | |||||
| 6-1 Month Momentum % | -1.78 | |||||
| 12-1 Month Momentum % | -6.69 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.04 | |||||
| Quick Ratio | 0.73 | |||||
| Cash Ratio | 0.21 | |||||
| Days Inventory | 113.71 | |||||
| Days Sales Outstanding | 52.58 | |||||
| Days Payable | 192.32 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.8 | |||||
| Dividend Payout Ratio | 0.37 | |||||
| Forward Dividend Yield % | 1.8 | |||||
| 5-Year Yield-on-Cost % | 1.8 | |||||
| Shareholder Yield % | 4.07 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 59.7 | |||||
| Operating Margin % | 17.66 | |||||
| Net Margin % | 9.28 | |||||
| FCF Margin % | 15.61 | |||||
| ROE % | 6.37 | |||||
| ROA % | 3.05 | |||||
| ROIC % | 4.38 | |||||
| ROC (Joel Greenblatt) % | 110.48 | |||||
| ROCE % | 7.01 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 29.19 | |||||
| Forward PE Ratio | 18.83 | |||||
| PE Ratio without NRI | 29.19 | |||||
| Price-to-Owner-Earnings | 19.69 | |||||
| PB Ratio | 1.85 | |||||
| Price-to-Free-Cash-Flow | 17.52 | |||||
| Price-to-Operating-Cash-Flow | 14.66 | |||||
| EV-to-EBIT | 18.54 | |||||
| EV-to-Forward-EBIT | 17.03 | |||||
| EV-to-EBITDA | 18.54 | |||||
| EV-to-Forward-EBITDA | 15.01 | |||||
| EV-to-Revenue | 3.41 | |||||
| EV-to-Forward-Revenue | 3.36 | |||||
| EV-to-FCF | 22.03 | |||||
| Earnings Yield (Greenblatt) % | 5.39 | |||||
| FCF Yield % | 5.86 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Haleon PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil £) | 11,302 | ||
| EPS (TTM) (£) | 0.114 | ||
| Beta | 0 | ||
| Volatility % | 16.82 | ||
| 14-Day RSI | 55.94 | ||
| 14-Day ATR (£) | 0.053363 | ||
| 20-Day SMA (£) | 3.25225 | ||
| 12-1 Month Momentum % | -6.69 | ||
| 52-Week Range (£) | 3.068 - 3.55 | ||
| Shares Outstanding (Mil) | 9,132.3 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Haleon PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Haleon PLC Stock Events
| Event | Date | Price(£) | ||
|---|---|---|---|---|
| No Event Data | ||||
Haleon PLC Frequently Asked Questions
What is Haleon PLC(LSE:HLN)'s stock price today?
The current price of LSE:HLN is £3.30. The 52 week high of LSE:HLN is £3.55 and 52 week low is £3.07.
When is next earnings date of Haleon PLC(LSE:HLN)?
The next earnings date of Haleon PLC(LSE:HLN) is 2024-08-02 Est..
Does Haleon PLC(LSE:HLN) pay dividends? If so, how much?
The Dividend Yield %  of Haleon PLC(LSE:HLN) is 1.8% (As of Today), Highest Dividend Payout Ratio of Haleon PLC(LSE:HLN) was 0.37. The lowest was 0.24. And the median was 0.24. The  Forward Dividend Yield % of Haleon PLC(LSE:HLN) is 1.8%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers